NEAL KLEIMAN to Stents
This is a "connection" page, showing publications NEAL KLEIMAN has written about Stents.
Connection Strength
2.755
-
Stenting: the Latest Frontier in Percutaneous Intervention. Methodist Debakey Cardiovasc J. 2018 Jan-Mar; 14(1):5-6.
Score: 0.393
-
Are we there yet? deciding when it is safe (and wise) to stop clopidogrel after stent implantation. J Interv Cardiol. 2014 Apr; 27(2):127-30.
Score: 0.302
-
Stent-assisted coil embolization of a large fusiform aneurysm of proximal anterior descending artery: novel treatment for coronary aneurysms. Circ Cardiovasc Interv. 2012 Feb 01; 5(1):e3-5.
Score: 0.261
-
Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction. Am Heart J. 2007 Jan; 153(1):41.e1-6.
Score: 0.183
-
Initial impact of drug-eluting stent use on the spectrum of patients undergoing percutaneous coronary intervention. Coron Artery Dis. 2006 May; 17(4):379-84.
Score: 0.175
-
Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol. 2006 Jan 03; 47(1):27-33.
Score: 0.170
-
Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: acute coronary syndromes and elective stenting. Am J Cardiovasc Drugs. 2004; 4(1):31-41.
Score: 0.149
-
Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists. Am Heart J. 2002 Apr; 143(4):594-601.
Score: 0.132
-
Meta-Analysis Investigating the Role of Optical Coherence Tomography Versus Intravascular Ultrasound in Low-Risk Percutaneous Coronary Intervention. Am J Cardiol. 2022 02 01; 164:136-138.
Score: 0.129
-
Never So Simple: Bedside Measurement of Platelet Reactivity and the Risk?of?Stroke After Coronary Stenting. JACC Cardiovasc Interv. 2018 07 09; 11(13):1287-1289.
Score: 0.101
-
New-Generation Coronary Stents: Current Data and Future Directions. Curr Atheroscler Rep. 2017 Mar; 19(3):14.
Score: 0.093
-
3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 Jun 07; 67(22):2565-74.
Score: 0.087
-
Stenting of a left main coronary artery compressed by a dilated main pulmonary artery. Catheter Cardiovasc Interv. 2013 Nov 01; 82(5):E684-7.
Score: 0.072
-
In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):E356-64.
Score: 0.071
-
In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry. Catheter Cardiovasc Interv. 2012 Dec 01; 80(7):1127-36.
Score: 0.066
-
Clinical outcomes of percutaneous interventions in saphenous vein grafts using drug-eluting stents compared to bare-metal stents: a comprehensive meta-analysisof all randomized clinical trials. Clin Cardiol. 2012 May; 35(5):291-6.
Score: 0.066
-
Searching for the ceiling: new reflections on the disposition and metabolism of clopidogrel. JACC Cardiovasc Interv. 2008 Dec; 1(6):628-30.
Score: 0.052
-
Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA. 2007 May 09; 297(18):2001-9.
Score: 0.047
-
Design of a registry to characterize "real-world" outcomes of percutaneous coronary revascularization in the drug-eluting stent era. Am Heart J. 2005 Nov; 150(5):887-92.
Score: 0.042
-
Could clopidogrel's platelet inhibition be enhanced by an increased loading dose and eptifibatide? Nat Clin Pract Cardiovasc Med. 2005 Jul; 2(7):344-5.
Score: 0.041
-
Evolving revascularization approaches for myocardial ischemia. Am J Cardiol. 2003 Nov 07; 92(9B):9N-17N.
Score: 0.037
-
Emerging Transcatheter Options for Tricuspid Regurgitation. Methodist Debakey Cardiovasc J. 2017 Jul-Sep; 13(3):120-125.
Score: 0.024
-
Red cell distribution width as a bleeding predictor after percutaneous coronary intervention. Am Heart J. 2013 Jul; 166(1):104-9.
Score: 0.018
-
Intravenous platelet blockade with cangrelor during PCI. N Engl J Med. 2009 Dec 10; 361(24):2330-41.
Score: 0.014
-
The effect of percutaneous coronary intervention on inflammatory response and endothelial progenitor cell recruitment. Catheter Cardiovasc Interv. 2008 Aug 01; 72(2):205-9.
Score: 0.013
-
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003 Feb 19; 289(7):853-63.
Score: 0.009
-
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). Am Heart J. 2002 May; 143(5):847-53.
Score: 0.008